Sanofi and partners’ success with repurposed antibodies for Covid-19 depend on recruiting less critically ill patients
DefenVid is an innovative nutraceutical of the lipofishin family. E-JUR-94013TM is the structural base of DefenVid, a bioderivative obtained from the species Trachurus trachurus (Atlantic horse mackerel).
Malvern Panalytical, with Concept Life Sciences (Cheshire, UK), has begun an innovative partnership that unites advanced instrumentation with proficient analytical services for discovery and development.
Treatment options for Covid-19 are urgently needed as the total number of confirmed cases globally rises to 550,000 on Friday and the US becomes the country with the most confirmed cases, at over 86,000. One of the potentially quickest ways to find treatment is to test substances already approved or in development for other indications.
The age of the battery is well underway. Lithium-ion batteries, for example, have already revolutionized our day-to-day lives – from smart mobile devices to pollution-free electric cars and intelligent power management solutions.
Aurora, a Phase III global trial presented by the National Kidney Foundation (NKF), has revealed a possible drug for the treatment of lupus kidney disease.